UBS AM’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.76M | Buy |
443,578
+284,431
| +179% | +$2.41M | ﹤0.01% | 1840 |
|
2025
Q1 | $1.28M | Sell |
159,147
-204,527
| -56% | -$1.64M | ﹤0.01% | 2205 |
|
2024
Q4 | $3.27M | Buy |
363,674
+65,220
| +22% | +$586K | ﹤0.01% | 1814 |
|
2024
Q3 | $2.19M | Sell |
298,454
-27,428
| -8% | -$201K | ﹤0.01% | 1994 |
|
2024
Q2 | $1.86M | Buy |
325,882
+165,734
| +103% | +$946K | ﹤0.01% | 2036 |
|
2024
Q1 | $802K | Hold |
160,148
| – | – | ﹤0.01% | 2114 |
|
2023
Q4 | $1.44M | Buy |
160,148
+12,447
| +8% | +$112K | ﹤0.01% | 1835 |
|
2023
Q3 | $1.15M | Sell |
147,701
-955
| -0.6% | -$7.42K | ﹤0.01% | 1883 |
|
2023
Q2 | $1.63M | Hold |
148,656
| – | – | ﹤0.01% | 1770 |
|
2023
Q1 | $1.63M | Buy |
148,656
+6,277
| +4% | +$68.8K | ﹤0.01% | 1770 |
|
2022
Q4 | $615K | Buy |
142,379
+51,569
| +57% | +$223K | ﹤0.01% | 2093 |
|
2022
Q3 | $683K | Sell |
90,810
-9,030
| -9% | -$67.9K | ﹤0.01% | 2188 |
|
2022
Q2 | $1M | Buy |
99,840
+47,100
| +89% | +$473K | ﹤0.01% | 1961 |
|
2022
Q1 | $653K | Sell |
52,740
-88,719
| -63% | -$1.1M | ﹤0.01% | 2356 |
|
2021
Q4 | $1.97M | Buy |
141,459
+129,178
| +1,052% | +$1.8M | ﹤0.01% | 1880 |
|
2021
Q3 | $272K | Sell |
12,281
-129,178
| -91% | -$2.86M | ﹤0.01% | 2638 |
|
2021
Q2 | $1.84M | Buy |
141,459
+21,300
| +18% | +$276K | ﹤0.01% | 1894 |
|
2021
Q1 | $1.56M | Buy |
120,159
+8,200
| +7% | +$107K | ﹤0.01% | 1860 |
|
2020
Q4 | $1.54M | Buy |
111,959
+12,700
| +13% | +$175K | ﹤0.01% | 1787 |
|
2020
Q3 | $1.46M | Buy |
99,259
+19,900
| +25% | +$292K | ﹤0.01% | 1681 |
|
2020
Q2 | $1.28M | Buy |
79,359
+5,900
| +8% | +$95.5K | ﹤0.01% | 1698 |
|
2020
Q1 | $1.05M | Buy |
73,459
+18,200
| +33% | +$261K | ﹤0.01% | 1678 |
|
2019
Q4 | $1.12M | Buy |
55,259
+38,800
| +236% | +$787K | ﹤0.01% | 1853 |
|
2019
Q3 | $87.9K | Buy |
16,459
+3,159
| +24% | +$16.9K | ﹤0.01% | 2676 |
|
2019
Q2 | $87.9K | Buy |
+13,300
| New | +$87.9K | ﹤0.01% | 2657 |
|